JP2011517447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517447A5
JP2011517447A5 JP2011501758A JP2011501758A JP2011517447A5 JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5 JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
seq
acid residues
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011501758A
Other languages
English (en)
Japanese (ja)
Other versions
JP5823858B2 (ja
JP2011517447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/011620 external-priority patent/WO2009120178A1/en
Publication of JP2011517447A publication Critical patent/JP2011517447A/ja
Publication of JP2011517447A5 publication Critical patent/JP2011517447A5/ja
Application granted granted Critical
Publication of JP5823858B2 publication Critical patent/JP5823858B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011501758A 2008-03-26 2008-10-08 抗vegf抗体 Active JP5823858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3971908P 2008-03-26 2008-03-26
US61/039,719 2008-03-26
PCT/US2008/011620 WO2009120178A1 (en) 2008-03-26 2008-10-08 Anti-vegf antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014102751A Division JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Publications (3)

Publication Number Publication Date
JP2011517447A JP2011517447A (ja) 2011-06-09
JP2011517447A5 true JP2011517447A5 (enExample) 2011-11-24
JP5823858B2 JP5823858B2 (ja) 2015-11-25

Family

ID=41114205

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011501758A Active JP5823858B2 (ja) 2008-03-26 2008-10-08 抗vegf抗体
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Country Status (9)

Country Link
US (2) US7803371B2 (enExample)
EP (1) EP2259795B1 (enExample)
JP (2) JP5823858B2 (enExample)
KR (1) KR101581244B1 (enExample)
CN (2) CN102065888B (enExample)
AU (1) AU2008353479B2 (enExample)
BR (1) BRPI0822556B1 (enExample)
CA (3) CA2719400C (enExample)
WO (1) WO2009120178A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2307454T (pt) 2008-06-25 2017-04-26 Esbatech Alcon Biomed Res Unit Anticorpos estáveis e solúveis que inibem o vegf
CN102002104A (zh) * 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物
WO2011047442A1 (en) * 2009-10-23 2011-04-28 Garvan Institute Of Medical Research Modified variable domain molecules and methods for producing and using same
BR112013021863A2 (pt) 2011-03-03 2016-11-22 Apexigen Inc anticorpos anti-receptor il-6 e métodos de uso
CN104650229A (zh) * 2011-11-02 2015-05-27 埃派斯进有限公司 抗-kdr抗体和使用方法
CN103417964A (zh) * 2012-05-17 2013-12-04 江苏先声药物研究有限公司 一种抗vegf抗体的用途
CN103417965B (zh) * 2012-05-17 2018-04-13 江苏先声药业有限公司 一种含有抗vegf抗体的药物组合物
US9745558B2 (en) 2013-02-18 2017-08-29 Vegenics Pty Limited VEGFR-3 ligand binding molecules and uses thereof
JP2016530244A (ja) * 2013-12-31 2016-09-29 ディベロップメント センター フォー バイオテクノロジーDevelopment Center For Biotechnology 抗vegf抗体及びその使用
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
US20180142038A1 (en) * 2015-01-16 2018-05-24 ALDER BIOPHARMACEUTICALS, INC. a/b/a ALDERBIO HOLDINGS LLC Anti-glycoprotein antibodies and uses thereof
CN107849105B (zh) * 2015-07-06 2021-09-17 Ucb生物制药有限责任公司 Tau结合抗体
GB201601073D0 (en) * 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
WO2017117464A1 (en) 2015-12-30 2017-07-06 Kodiak Sciences Inc. Antibodies and conjugates thereof
BR112020017872A2 (pt) 2018-03-02 2020-12-22 Kodiak Sciences Inc. Anticorpos de il-6 e construtos de fusão e conjugados dos mesmos
KR20220093103A (ko) * 2019-09-13 2022-07-05 어드메어 테라퓨틱스 소사이어티 항종양용해 바이러스 항원 항체 및 이의 사용 방법
WO2021072265A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
IL321781A (en) * 2022-12-29 2025-08-01 Ltz Therapeutics Inc Anti-cd79b antibodies and uses thereof
CN118344476B (zh) * 2024-05-16 2024-11-15 武汉爱博泰克生物科技有限公司 人c反应蛋白单克隆抗体、抗体对和检测试剂或试剂盒及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1308347C (zh) * 1999-04-28 2007-04-04 德克萨斯大学董事会 用于通过选择性抑制vegf来治疗癌症的组合物和方法
CN1299833A (zh) * 1999-12-30 2001-06-20 华西医科大学口腔医学研究所 抗人血管内皮生长因子单链抗体及其制备方法
US20040185040A1 (en) * 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
JP2005535341A (ja) * 2002-08-15 2005-11-24 エピトミスク インコーポレーティッド ヒト化ウサギ抗体
CA2533830A1 (en) * 2003-08-07 2005-02-24 Epitomics, Inc. Methods for humanizing rabbit monoclonal antibodies
US7462697B2 (en) * 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
US7431927B2 (en) * 2005-03-24 2008-10-07 Epitomics, Inc. TNFα-neutralizing antibodies
KR101834797B1 (ko) * 2008-06-25 2018-03-07 에스바테크 - 어 노바티스 컴파니 엘엘씨 보편적 항체 프레임워크를 사용한 래빗 항체의 인간화
CN102002104A (zh) * 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物

Similar Documents

Publication Publication Date Title
JP2011517447A5 (enExample)
JP2014205674A5 (enExample)
JP2009225799A5 (enExample)
JP2013198490A5 (enExample)
JP2020079252A5 (enExample)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2012010714A5 (enExample)
JP2015504421A5 (enExample)
JP2022031635A5 (enExample)
JP2011518125A5 (enExample)
JP2017514461A5 (enExample)
JP2014526898A5 (enExample)
JP2013519364A5 (enExample)
JP2018521638A5 (enExample)
JP2011173884A5 (enExample)
AU2016204274A1 (en) Antibodies that bind to OX40 and their uses
IL290591B1 (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins
JP2010534478A5 (enExample)
JP2013538057A5 (enExample)
JP2010536384A5 (enExample)
RU2017114341A (ru) Антитела к pd-l1, связывающие pd-l1 собаки
JP2012525829A5 (enExample)
NZ718973A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
JP2017052784A5 (enExample)
PE20081185A1 (es) Anticuerpos que se unen a interleucina 13 (il-13) humana y composiciones farmaceuticas que lo comprenden